Drug application
IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE (DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN)
Drugs@FDA ANDA 210676 · AUROBINDO PHARMA LTD
Key facts
| Drug name | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE |
|---|---|
| Active ingredients | DIPHENHYDRAMINE HYDROCHLORIDE, IBUPROFEN |
| Application type | ANDA |
| Application number | 210676 |
| Company | AUROBINDO PHARMA LTD |
| Dosage forms | CAPSULE, ORAL |
| Strength | 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT |
| Marketing status | Over-the-counter |
| Reference listed drug | No |
| Latest submission status date | Feb 14, 2019 |
At a glance
- 1–9 Submissions
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.